Search research articles
Contact Us
Filters
Showing results (201-210 of 245) with videos related to
Page
of 25
Sort By:
Pediatric Neurosurgery
|
January 22, 2004
Treatment of spinal involvement in neuroblastoma patients
David I Sandberg, Mark H Bilsky, Brian H Kushner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers
N K Cheung, B H Kushner, M P LaQuaglia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 2019
Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial
Dana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Molecular Cancer Therapeutics
|
August 28, 2019
Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer
William B Kietzman, Garrett T Graham, Virginie Ory, et al.
Cancer
|
March 3, 2015
Osteochondroma in long-term survivors of high-risk neuroblastoma
Brian H Kushner, Stephen S Roberts, Danielle N Friedman, et al.
Journal of Pediatric Hematology/Oncology
|
July 11, 2017
Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk Neuroblastoma
Anne Stone, Danielle Novetsky Friedman, Stefan Worgall, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 23, 2012
Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience
Neil B Desai, Nicholas F Stein, Michael P LaQuaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age
B H Kushner, M P LaQuaglia, M A Bonilla, et al.
Experimental Cell Biology
|
January 1, 1988
Anti-tumor efficacy of interleukin-2-activated killer cells in human neuroblastoma ex vivo
J Atzpodien, S C Gulati, J H Kwon, et al.
Pediatric Blood & Cancer
|
August 14, 2019
Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma
Anne Stone, Danielle Novetsky Friedman, Brian H Kushner, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 245) with videos related to
Sort By:
Page
of 25
Pediatric Neurosurgery
|
January 22, 2004
Treatment of spinal involvement in neuroblastoma patients
David I Sandberg, Mark H Bilsky, Brian H Kushner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers
N K Cheung, B H Kushner, M P LaQuaglia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 2019
Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial
Dana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Molecular Cancer Therapeutics
|
August 28, 2019
Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer
William B Kietzman, Garrett T Graham, Virginie Ory, et al.
Cancer
|
March 3, 2015
Osteochondroma in long-term survivors of high-risk neuroblastoma
Brian H Kushner, Stephen S Roberts, Danielle N Friedman, et al.
Journal of Pediatric Hematology/Oncology
|
July 11, 2017
Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk Neuroblastoma
Anne Stone, Danielle Novetsky Friedman, Stefan Worgall, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 23, 2012
Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience
Neil B Desai, Nicholas F Stein, Michael P LaQuaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age
B H Kushner, M P LaQuaglia, M A Bonilla, et al.
Experimental Cell Biology
|
January 1, 1988
Anti-tumor efficacy of interleukin-2-activated killer cells in human neuroblastoma ex vivo
J Atzpodien, S C Gulati, J H Kwon, et al.
Pediatric Blood & Cancer
|
August 14, 2019
Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma
Anne Stone, Danielle Novetsky Friedman, Brian H Kushner, et al.
Page
of 25